Metraipolis › archive › dc_f995afa74ec4

Targeting the MEK/ERK Pathway to Suppress P-Glycoprotein and Reverse Carfilzomib Resistance in Multiple Myeloma — Europe PMC PMID:41373605

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41373605
DOI
10.3390/ijms262311448
License (as archived)
solo-consultazione
Archived
2026-11-08T05:51:19.037Z
SHA-256 of the archived text
ce1104e810017d7ca9dc6f4add017b3e144d9f5db5290c4985243f5b6b048a9b
Stable URL of this page
https://metraipolis.com/documento/dc_f995afa74ec4

How to cite

Targeting the MEK/ERK Pathway to Suppress P-Glycoprotein and Reverse Carfilzomib Resistance in Multiple Myeloma — Europe PMC PMID:41373605 — Europe PMC (en), https://europepmc.org/article/MED/41373605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f995afa74ec4 (Metraipolis archive dc_f995afa74ec4, sha256 ce1104e810017d7ca9dc6f4add017b3e144d9f5db5290c4985243f5b6b048a9b)
BibTeX
@misc{dcf995afa74ec4,
  title = {Targeting the MEK/ERK Pathway to Suppress P-Glycoprotein and Reverse Carfilzomib Resistance in Multiple Myeloma — Europe PMC PMID:41373605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41373605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f995afa74ec4; sha256 ce1104e810017d7ca9dc6f4add017b3e144d9f5db5290c4985243f5b6b048a9b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41373605. Agents can read the archived copy with the MCP tool read_document.